Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing

Moderna

Our mission is to deliver the greatest possible impact to people through mRNA medicines.

Founded 2010

Cambridge, United States 6245 employees Grant Total: $3.91B Biotechnology, Health Care +2

General Information

Company Name Moderna

Founded Year 2010

Location

Cambridge, United States +2

Founders / Decision Makers

Employees 6245

Industries Biotechnology, Health Care, Health and Wellness +1

Funding Stage Grant

Social

Get notified when Moderna moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Track Moderna

Get real-time alerts for funding, hiring, news, and 40+ signal types.

See how it works

Discover More

United States Market

Market Signals All Companies

Biotechnology

Industry Signals All Companies in United States

Moderna Alternatives

All Signals Trend Reports

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

In The News Aug 31, 2026

Featured on Cnbc: August was the month of the comeback kids. Cramer reviews what drove the biggest...

In The News Aug 19, 2026

Featured on Cnbc: Target earnings, Canada tariffs, American Airlines' seatback screens and more in...

Get alerts when Moderna shows new signals

AI Insight

Bounce Watch AI

2 months ago

Moderna is demonstrating robust strategic momentum, securing a prestigious recognition as a top impactful company while simultaneously expanding its R&D capabilities through a scientific collaboration with the University of Oxford focused on cancer prevention. This strategic push is complemented by recent UK regulatory approval for a new mRNA clinical study, highlighting the company's continuous pipeline progression and targeted international market entry. These developments underscore Moderna's dynamic pursuit of innovation and market leadership in the mRNA therapeutics space.

Signal Types

Recognition Partnership Regulatory Approval R&D Progress

Strategic Labels

R&D Expansion Strategic Partnerships Market Access

Next Move: Development

Impact: 9/10

Ideal For: Biotech Growth Investors — Public Equity / Late-Stage

About Moderna

Moderna, founded in 2010, has established itself as a trailblazer in the Biotechnology and Pharmaceutical industries, with a focus on developing mRNA medicines. The company's mission, "to deliver the greatest possible impact to people through mRNA medicines," highlights its dedication to transforming healthcare by innovating treatments for infectious diseases, cancer, and rare diseases.

With its headquarters in the United States, Moderna benefits from a robust technology platform and a global workforce that embodies the company's values and culture. The organization’s advancements have attracted significant interest, epitomized by a recent $176.00M grant investment from the U.S. Department of Health & Human Services on July 2, 2024.

This investment underscores confidence in Moderna's potential to innovate in health care, making it a compelling opportunity for investors seeking to support cutting-edge medical breakthroughs.

Taxonomy: mRNA Medicines, Vaccines Development, Therapeutics, Infectious Diseases, Cancer Treatment, Rare Diseases, Drug Modality, Genetic Disorders, Oncology, In Vivo Therapeutics, Strategic Partnerships, Protein Production, Antibody Production, Safety Monitoring

Services & Products

mRNA Medicine Development

Clinical Trials Execution

Biotechnology Research

Medical Affairs in Oncology

Drug Manufacturing and Testing

Target Customers

Healthcare Professionals Patients Medical Researchers Global Medical Institutions Pharmaceutical Companies

Funding Rounds & Investors (15)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	••••••	1	•••• ••••	02 Jul 2024
Post-IPO Equity	••••••	1	•••• ••••	27 Mar 2024
Post-IPO Equity	••••••	1		12 Oct 2022
Grant	••••••	1	•••• ••••	26 Jul 2020
Grant	••••••	1	•••• ••••	17 Apr 2020

View All 15 Funding Rounds

Latest News

View All

CureVac's patent infringement case against BioNTech has $500M of 'potential upside': analyst

Fiercepharma.com Jul 12, 2022

How AI can accelerate R&D for cell and gene therapies

Mckinsey.com Nov 16, 2022

Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump

Cnbc Mar 27, 2024

Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold

Cnbc May 06, 2024

Moderna says FDA delayed RSV vaccine approval to end of May

Cnbc May 10, 2024

FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product

Cnbc May 31, 2024

Moderna Alternatives & Competitors

View All Alternatives

Moderna vs

Precigen United States

Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of gene and cel...

Post Ipo Equity

152 employees

Biotechnology, Health and Wellness

Compare Moderna vs Precigen

Moderna vs

Amgen United States

#WeareBiotech

IPO

40947 employees

Biotechnology, Health Care

Compare Moderna vs Amgen

View all alternatives

FAQ About Moderna

Our mission is to deliver the greatest possible impact to people through mRNA medicines.

Moderna was founded in 2010.

Moderna is headquartered in Cambridge, United States.

Moderna operates in the following industries: Biotechnology, Health Care, Health and Wellness, Pharmaceutical.

Moderna has approximately 6245 employees.

Moderna has completed 15 funding rounds, raising a total of $3.91B. The latest funding stage is Grant.

Moderna offers: mRNA Medicine Development, Clinical Trials Execution, Biotechnology Research, Medical Affairs in Oncology, Drug Manufacturing and Testing.

Top alternatives and competitors to Moderna include Precigen, Amgen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Moderna and Precigen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Moderna and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.